Immunoprecipitation assays using a Trim25 antibody confirmed the interaction between Trim25 and endogenous ITPKB in glioma cells, with a weaker interaction observed in resistant cell lines compared to sensitive cells (Fig. 4d). The gene discussed is ITPKB; the disease is central nervous system cancer.